- Clinical trials are research studies that test whether a new treatment is safe and effective; they are research, not guaranteed treatment.
- Type 1 diabetes research explores new insulins, devices, immune therapies, and prevention studies for at-risk relatives.
- You can search current studies on ClinicalTrials.gov, and organizations like the ADA and NIDDK share research information.
- Informed consent means you receive full information, can ask questions, and can withdraw from a study at any time.
- Never stop or reduce your insulin on your own to qualify for or join a trial; changes must be guided by your care team.
- Discuss any trial with your endocrinologist or diabetes care team before enrolling.
Type 1 diabetes is a lifelong condition in which the body makes little or no insulin, and daily insulin is essential for staying well. Research is active and hopeful: scientists are studying new insulins, smarter devices, immune-modifying therapies, and even ways to delay or prevent the disease in people at high risk. Clinical trials are how these approaches are tested. But a trial is a research study, not guaranteed treatment, so it helps to understand how they work before you consider one. This guide explains what type 1 diabetes clinical trials are, the phases involved, how to find studies, what informed consent means, and the safety rules that matter most.
What is a clinical trial?
A clinical trial is a research study that tests a medical approach, such as a new medication, device, or therapy, in people. The goal is to answer specific questions: Is it safe? What dose or setting works best? Does it help more than existing options or a placebo? Because these questions are still being answered, participation involves some uncertainty. A trial is designed to generate knowledge, and while participants may benefit, benefit is never guaranteed and is not the study’s only purpose.
Type 1 diabetes research is broad. Trials may study next-generation insulins, automated insulin-delivery (“artificial pancreas”) systems, continuous glucose monitors, immune therapies aimed at protecting insulin-producing cells, islet-cell and stem-cell approaches, and prevention studies in relatives who carry certain autoantibodies. Understanding a diagnostic like what an insulin test measures can help you follow the science behind some of these studies.
The phases of clinical trials
New treatments generally move through a series of phases, each with a different question and size.
| Phase | Main question | Typical scope |
|---|---|---|
| Phase 1 | Is it safe, and what is a tolerable dose? | Small group of participants |
| Phase 2 | Does it appear to work, and what are the side effects? | Larger group |
| Phase 3 | Is it effective compared with standard care or placebo? | Large groups, often at multiple sites |
| Phase 4 | What are the long-term effects after approval? | Post-approval monitoring |
Many trials use a control group and randomization, and some are “blinded,” meaning participants (and sometimes researchers) do not know who receives the investigational treatment versus a comparison. These designs help produce reliable answers, but they also mean you may not receive the new treatment. You can see the same structure in how trials work for other conditions.
How to search for type 1 diabetes trials
The main US resource is ClinicalTrials.gov, a registry run by the National Institutes of Health that lists clinical studies conducted around the world. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the American Diabetes Association (ADA) also share information about diabetes research and how to get involved. You can search by condition (such as “type 1 diabetes”), location, and recruitment status. Each listing describes the study’s purpose, eligibility criteria, locations, and contact information. As you read, note the eligibility rules: inclusion criteria (characteristics you must have) and exclusion criteria (things that would keep you out), which often relate to age, how long you have had diabetes, autoantibody status, or current treatments. For a broader, evidence-first view of testing and everyday care, our evidence-first wellness guides take a careful approach throughout.
Informed consent and your rights
Before joining any trial, you go through informed consent. The research team must explain the study’s purpose, procedures, potential risks and benefits, alternatives, and what is expected of you, in language you can understand, and give you time to ask questions. Key protections include:
- Participation is voluntary, and you can decline without affecting your regular care.
- You can withdraw from a study at any time, for any reason.
- Trials are reviewed by an independent ethics board (an Institutional Review Board) that helps protect participants.
- For a child’s participation, a parent or guardian provides permission, and the child may be asked for assent.
- You should understand any costs, travel, time commitment, and what happens to your treatment when the study ends.
Consent is an ongoing conversation, not just a signature. Ask as many questions as you need.
Never stop insulin on your own
This is the most important safety point. Insulin is life-sustaining in type 1 diabetes, and stopping or cutting back can quickly lead to dangerously high blood sugar and diabetic ketoacidosis, a medical emergency. Never stop, reduce, or change your insulin on your own to qualify for or join a trial. A well-run study will not ask you to do that unsafely; any change to your regimen should be planned and monitored by your endocrinologist or diabetes care team together with the research team. Joining a trial is a medical decision, so involve the people who manage your care. They can help you weigh whether a study fits your situation, what the realistic pros and cons are, and how it interacts with your current treatment and glucose monitoring.
Frequently asked questions
Will a clinical trial cure type 1 diabetes? No trial can promise that. Trials test whether treatments are safe and effective; participation is research, and benefit is possible but not guaranteed.
Where do I find type 1 diabetes trials? ClinicalTrials.gov is the main US registry, and NIDDK and the ADA share information about diabetes research and participation.
Can family members without diabetes join studies? Sometimes. Certain prevention studies enroll relatives who carry specific autoantibodies; listings explain eligibility.
Might I receive a placebo? It depends on the study. Many trials continue standard care, and the consent process explains exactly what each group receives.
Do I have to pay to join? Study treatment is often provided, but costs vary. Ask about expenses, travel, and coverage before enrolling.
Should I stop insulin to qualify? Never do this on your own. Insulin is essential, and any change must be guided by your care team and the research staff.
This article is for general education and is not medical advice. Supplements and therapies affect people differently and can interact with medications or conditions. Talk to your doctor, pharmacist, or a licensed clinician before making changes to your health routine.
Sources
- ClinicalTrials.gov — US registry of clinical studies and how to search it
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) — type 1 diabetes and research
- American Diabetes Association (ADA) — diabetes research and participating in studies
- National Institutes of Health (NIH) — basics of clinical trials and participant protections
- MedlinePlus — type 1 diabetes and clinical trials overviews
- U.S. Food and Drug Administration (FDA) — clinical trial phases and drug development